Once fully operational, the Pennsylvania site will employ more than 500 people and make cell therapies for thousands of patients a year.

With $55 billion earmarked to bolster its U.S. operations, Johnson & Johnson is the latest drugmaker to zero in on expansion ...

Johnson & Johnson, the healthcare and lifestyle giant announced a more than $1 billion dollar investment in next generation ...

Johnson & Johnson plans to spend more than $1 billion to build a cell therapy manufacturing facility in Montgomery County ...

Chinese researchers have developed a new stem cell therapy for Parkinson’s disease which reportedly provides rapid improvement in symptoms for patients suffering for decades from the neurological ...

Discover how Treg cell therapies rethink precision medicine for autoimmune diseases like type 1 diabetes, MS, and transplant rejection.

Chinese scientists have achieved the world's first reversal of type-2 diabetes using stem-cell therapy. Here is what you need ...

In 2024, Professor Sebastian Kobold's research group at LMU University Hospital had already shown that the metabolite ...

The Commonwealth has secured over $1 billion in private-sector investment from global health care company Johnson & Johnson to build a next generation cell therapy manufacturing facility in Montgomery ...

Jefferson Health oncologist Jennifer Johnson had exhausted all the standard treatment options for her 49-year-old patient ...

Auggie, a Great Pyrenees, was successfully treated with VetStem Cell Therapy for osteoarthritis in his hips. Auggie ...